Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Ophthalmologists (EU)

Articles with lock require a subscription to GLG News | Request a free trial
April 7, 2008
Visudyne teraphy may play a new role in AMD treatment
Analysis of: Positive Results From Visudyne (R) Combination Therapy Study Reported at Annual Macula Society Conference | www.pipelinereview.com
Author: GLG Expert Contributor
1. AMD 2. Anti VEG 3. Visudyne
March 5, 2008
New molecule for the treatment of rheumatoid arthritis with minor toxicity.
Analysis of: Glenmark’s molecule for Rheumatoid Arthritis - GRC 4039 | www.pipelinereview.com
Author: GLG Expert Contributor
1. Rheumatoid arthritis as an invalidating disease (1% population). 2. Anti TNF-α agents. 3. Clinical trial for inflammatory disorders by Glenmark.
March 5, 2008
Decreasing the risk of complications in the treatment of wet AMD.
Analysis of: MacuSight Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration | pharmalive.com
Author: GLG Expert Contributor
1. Wet AMD. 2. Macular edema. 3. Intravitreal injection.
March 5, 2008
Choosing the best treatment for wet AMD.
Analysis of: Comparison of AMD Treatments Trials (CATT): Lucentis — Avastin Trial | www.pipelinereview.com
Author: GLG Expert Contributor
1. Lucentis. 2. Avastin. 3. Cost.
March 5, 2008
Keeping the privacy of health data.
Analysis of: Google to store patients' health records | news.yahoo.com
Author: GLG Expert Contributor
1. Internet. 2. Medical records. 3. Privacy.
February 19, 2008
New promising agent for glaucoma treatment
Analysis of: Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma | www.pipelinereview.com
Author: GLG Expert Contributor
1. Glaucoma therapy 2. IOP reduction 3. Combined therapy
February 18, 2008
New promising glaucoma agent for glaucoma treatment
Analysis of: Biovitrum has Completed an Exploratory Clinical Phase II Study in Glaucoma | www.pipelinereview.com
Author: GLG Expert Contributor
1. glaucoma treatment 2. combined therapy 3. IOP reduction
August 13, 2007
Eyelid basal cell carcinoma
Analysis of: Basal Cell Carcinoma of the Eyelids | www.medscape.com
Author: GLG Expert Contributor
1. Eyelid basal cell carcinoma. 2. Health problem. 3. Early diagnostic and correct surgery treatment. 4. Risk factors and prevention.
August 10, 2007
Bimatoprost is known to be slighatly more potent that prostaglandin
Analysis of: Bimatoprost May Provide Better Intraocular Pressure Control Than Latanoprost | www.medscape.com
Author: GLG Expert Contributor
1. Exfoliative glaucoma is specillay difficult to treat medically. 2. Prostaglandin. 3. Early surgery. 4. Lesser costs.
July 26, 2007
CVS/Pharmacy stores for medical basic assistence.
Analysis of: An Innovation in Health Care Opens at CVS/Pharmacy Stores in Knoxville and Chattanooga | money.cnn.com
Author: GLG Expert Contributor
1. Medical asistance. 2. Health unexpensiveness. 3. Posibility of multiple medical offices. 4. Quality of services.

Page : 11 to 10 of 10

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203